Mild Cognitive Impairment (MCI) clinical trials
Showing 51–100 of 228 active trials. Describe your situation to see which ones look like a fit.
- Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease
- Treating Insomnia in Mild Cognitive Impairment
- Low Intensity Focused Ultrasound for Mild Cognitive Impairment and Mild Alzheimer's Disease
- Enhancing Attention in Elderly Using a Brain-Computer-Interface
- Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone
- Brain Stimulation and Cognitive Training for MCI
- Biomarker-based Trial of NPC-1 for Alzheimer's Pathology
- NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE
- A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- OTC Hearing Aid and MCI
- Effects of Accelerated rTMS on Cognitive Function
- Anxiety Sensitivity Treatment to Reduce Anxiety in Alzheimer's
- A Primary Care-Based Psychosocial Intervention To Improve Cognitive & Depression Outcomes in Older Adults With MCI & Early Stage AD
- A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
- Early Age-Related Hearing Loss Investigation (EARHLI)
- Multi-modal Large Language Model-Empowered Talk Therapy for Older Adults With ADRD
- Early-Stage Partner in Care Living Alone Plus
- Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia
- Study to Investigate Vagus Nerve Stimulation to Augment Executive Function in Healthy and Cognitively Impaired Populations
- Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
- A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
- ACT for Individuals With MNCD and Their Care Partners
- Safety And Tolerability Of Gamma Glutamylcysteine (GGC) Oral Supplementation In MCI Patients
- CogT pSOPT Intervention Study
- Reducing African American's Alzheimer's Risk Through Exercise-Mild Cognitive Impairment (RAATE-MCI)
- The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay Dementia
- Effect of Daily Mixed Spice Consumption on Memory Function
- Voice Technology-Based Self-Management Intervention
- A Study of Dual-task Exercise Training to Prevent Falls Among Older Adults With Mild Cognitive Impairment
- Studying the Effects of Digital Interventions on Cognition, Wellbeing, Stress, and Sleep in Older Adults
- Sense4Safety Intervention
- Feasibility and Adherence to a Technology-assisted Home-based Strength Training Program in Adults With Type 2 Diabetes Mellitus and Mild Cognitive Impairment
- The INSPIRE -Faith Study: Intervention Strategies for Preserving Intellectual Resilience and Engagement
- Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
- Enhancing Attention and Wellbeing Using Digital Therapeutics
- Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study
- Natives Engaged in Alzheimers Research - 'Ike Kupuna
- Goal Setting to Promote Physical Activity Adherence in Midlife Adults
- Disease Modifying Potential of 5mg of Melatonin on Cognition and Brain Health in Aging
- Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
- Cognitive Screening Made Easy for PCPs - Administrative Supplement
- Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease
- PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
- Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease
- Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol
- PET Tau - Neurodegenerative Disease Imaging
- PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
- Exploring the Utility of [18F]3F4AP for Demyelination Imaging
- Superior Parietal iTBS for PD-MCI
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.